- Perrigo (NYSE:PRGO +0.3%) exclusively licenses Flamel Technologies' (FLML +1.5%) LiquiTime. The platform will be used to develop a portfolio of extended release suspension products targeted to the U.S. OTC market. Specific financial terms are not disclosed.
- LiquiTime, a liquid suspension of small drug-coated microparticles, can be applied to a wider range of medicines than ion exchange resin technology.
Perrigo licenses Flamel's LiquiTime platform for liquid suspension formulations
Recommended For You
About PRGO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
PRGO | - | - |
Perrigo Company plc |